Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo

Applied Biochemistry and Biotechnology
Kok-Tong TanYu-Tang Tung

Abstract

Lung cancer remains a highly prevalent disease and a leading cause of cancer-related deaths worldwide. Currently, exploring antitumor drugs derived from herbs used in traditional Chinese medicine is increasingly becoming an attractive area of research. Paclitaxel (PTX), a highly effective chemotherapeutic drug, is widely used for treating different cancers; however, the clinical use of PTX is dose limited because of its adverse side effects. Chemotherapeutic agents are being developed to enhance the anticancer activity of PTX, particularly for use in combination therapy. 5-Demethylnobiletin (5-DMN), a natural, active compound isolated from orange peel, has been reported to induce apoptosis in several cancer cell lines. In this study, we tested the synergistic anticancer antiproliferative effects of combinations of PTX and 5-DMN on CL1-5 lung cancer cells through the MTT and propidium iodide assays. After low-dose combination treatments (PTX and 5-DMN), a reduction in cell viability and a concomitant increase in apoptosis were observed in the CL1-5 cells. We propose that 5-DMN cooperates with PTX to induce apoptosis via the caspase pathway (by modulating caspase-3, caspase-8, and caspase-9 activities). Furthermore, we observed t...Continue Reading

References

Oct 6, 1997·American Journal of Respiratory Cell and Molecular Biology·Y W ChuC W Wu
Feb 2, 2006·International Journal of Cancer. Journal International Du Cancer·Jérôme AlexandreFrançois Goldwasser
Oct 13, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Shiming LiChi-Tang Ho
Apr 24, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Gilbert KochJohannes Schropp
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nikolaus SchicherChristoph Hoeller
Oct 21, 2009·Cancer Chemotherapy and Pharmacology·Kosalaram GotetiPatrick J Brassil
Oct 27, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M RocchettiG De Nicolao
Apr 17, 2010·Molecular Nutrition & Food Research·Peiju QiuHang Xiao
May 8, 2013·International Journal of Cancer. Journal International Du Cancer·Feifei LiLili Wang
Sep 13, 2014·Molecular Biology of the Cell·Beth A Weaver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.